Takeda Pharmaceutical (TAK) Total Current Liabilities (2017 - 2026)
Takeda Pharmaceutical's Total Current Liabilities was $17.34 billion in the quarter ended Jun 30, 2026, up 15.7% from $14.99 billion a year earlier but down 4.0% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Total Current Liabilities (2017 - 2026) Analysis & Trends
As of Mar 31, 2026, Total Current Liabilities at Takeda Pharmaceutical came in at $18.81 billion, up 14.3% from the prior year.
- Total Current Liabilities shows a five-year compound annual growth rate of 2.4% (years ended Mar 2021 to Mar 2026).
- In earlier years, Total Current Liabilities was $16.45 billion in the year ended Mar 31, 2025 (+2.6%), $16.04 billion in the year ended Mar 31, 2024 (-12.7%), $18.37 billion in the year ended Mar 31, 2023 (-3.9%) and $19.11 billion in the year ended Mar 31, 2022 (+14.3%).
- Quarterly Total Current Liabilities has moved between $13.8 billion (the quarter ended Dec 31, 2024) and $18.76 billion (the quarter ended Mar 31, 2023) over five years.
- Compared with a year earlier, Total Current Liabilities has increased for three straight quarters, with growth averaging 3.3% over the last eight quarters.
- The best year-over-year quarter for Total Current Liabilities over five years was the quarter ended Dec 31, 2025 (growth of 22.9%); the worst was the quarter ended Mar 31, 2024 (a decline of 16.8%).
- Per Business Quant data, TAK's Total Current Liabilities in the three quarters before the quarter ended Jun 30, 2026 was $18.06 billion (quarter ended Mar 31, 2026), $16.96 billion (quarter ended Dec 31, 2025) and $14.52 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Takeda Pharmaceutical | 2.74 Bn | -23.77 Bn | 5.10 Bn | 17.34 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.34 Bn |
| Mar 31, 2026 | 18.06 Bn |
| Dec 31, 2025 | 16.96 Bn |
| Sep 30, 2025 | 14.52 Bn |
| Jun 30, 2025 | 14.99 Bn |
| Mar 31, 2025 | 16.43 Bn |
| Dec 31, 2024 | 13.80 Bn |
| Sep 30, 2024 | 16.00 Bn |
| Jun 30, 2024 | 15.84 Bn |
| Mar 31, 2024 | 15.61 Bn |
| Dec 31, 2023 | 15.44 Bn |
| Sep 30, 2023 | 16.39 Bn |
| Jun 30, 2023 | 18.26 Bn |
| Mar 31, 2023 | 18.76 Bn |
| Dec 31, 2022 | 15.83 Bn |
| Sep 30, 2022 | 17.32 Bn |
| Jun 30, 2022 | 16.76 Bn |
| Mar 31, 2022 | 18.46 Bn |
| Jun 30, 2021 | 15.59 Bn |
| Mar 31, 2021 | 16.75 Bn |
API Access
Takeda Pharmaceutical Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();